Uncontrolled DCD donors suffer cardiac arrest followed by unsuccessful resuscitation. Their livers have been successfully transplanted, though strict maintenance and selection criteria are necessary to avoid adverse outcomes, namely ischemic type biliary lesions. We demonstrated that uDCD liver recipients develop severe coagulopathy and fibrinolysis (Blasi 2016). Given the liver is the major source of clotting and fibrinolytic factors, we hypothesized that changes in gene expression may be detected in uDCD livers and provide a basis for abnormalities observed. Methods: 32 samples were taken from 16 uDCD livers: "A" before cold preservation and "B" after reperfusion. Total RNA was extracted and analyzed using microarrays; results were confirmed using RT-PCR. Finally, 61 biopsies from 38 uDCD livers were evaluated by light microscopy to rule out fibrin microthrombi. Results: Both before preservation and after reperfusion, uDCD livers had significantly upregulated expression of genes that provoke fibrinolysis and inhibit coagulation, including TPA, urokinase plasminogen activator, urokinase plasminogen activator receptor, and thrombomodulin. There was also decreased expression of genes implicated in hemostasis (vWF) and inhibition of fibrinolysis (alpha-2macroglobulin):
On histology, no fibrin microthrombi were detected, even in cases that developed ITBL (13%). Conclusion: Changes in gene expression in uDCD livers help explain severe coagulopathy and fibrinolysis in recipients. Endogenous fibrinolysis is upregulated in these livers most at risk for ITBL, and clinical DCD protocols using TPA to help prevent ITBL should undergo critical appraisal. Various outflow reconstruction methods have been devised to prevent congestion. An expanded polytetrafluoroethylene (ePTFE) graft may be used for anterior section drainage. We recently experienced several cases of injuries of adjacent organs caused by ePTFE grafts. The aim of this study was to explore these rare complications and their clinical outcomes in a single center. Methods: From January 2005 to December 2016, 638 patients underwent RL living donor liver transplantation draining MVH branches with ePTFE grafts. Medical records of recipients who developed ePTFE-related adjacentorgan injuries were retrospectively reviewed. Results: ePTFE-related adjacent-organ injuries developed in 5 patients (0.78%). The mean interval between transplantation and identification of injury was 73.4AE38.1 months. All patients presented with dyspepsia. ePTFE graft induced injury of the gastric antrum or duodenal bulb was observed in 3 patients, one at the small bowel with fistula formation, and another at the common bile duct (CBD). Such injuries were identified by gastroscopy and computed tomography (CT). The patient with gastric antrum perforation did not receive aggressive treatment although the remaining graft penetrated the gastric wall but no leakage. In one patient with duodenal bulb injury, ePTFE graft was removed with gastroscopy. In the remaining 3 patients, surgical exploration and ePTFE graft removal was performed. Conclusion: Although the incidence of adjacent-organ injuries by ePTFE graft is rare, close monitoring of ePTFE grafts is necessary since unexpected injuries can occur during long-term follow-up.
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